Li Wang

Li Wang, PhD, MBA, MS, is the Director of Epidemiology at Pfizer, where they focus on epidemiology and the application of real-world evidence. They have extensive experience in translational epidemiology, contributing to 13 research publications and holding one biomedical invention patent. Prior roles include postdoctoral fellow at The Henry M. Jackson Foundation and various positions at the FDA, where they provided policy support and technical evaluation in clinical trials. Li earned a Ph.D. in Molecular Medicine and Translational Science from Wake Forest University, along with an MBA from its Babcock Graduate School of Management.